Antonio González-Martı́n

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

The use of maintenance therapy with olaparib provided a substantial benefit with regard to progression-free survival among women with newly diagnosed advanced ovarian cancer and...

Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

Among patients with newly diagnosed advanced ovarian cancer who had a response to platinum-based chemotherapy, those who received niraparib had significantly longer progression-...

Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer

In patients with advanced ovarian cancer receiving first-line standard therapy including bevacizumab, the addition of maintenance olaparib provided a significant progression-fre...